{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:44:01Z","timestamp":1791960241432,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Despite an increasing number of publications on Peyronie\u2019s disease (PD), evidence-based clinical decision-making remains challenging due to the small number of well-designed clinical trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To perform a critical analysis of reporting quality in PD systematic reviews (SR) and meta-analyses (MA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Study protocol registration was performed on the Open Science Framework platform. In January 2021, a systematic electronic search of the Medline\/PubMed, Embase, Ovid, Scopus, Joanne Briggs Institute, and Cochrane databases was performed. Search terms included \u201cPeyronie\u2019s disease\u201d and \u201csystematic review OR meta-analysis OR meta-analysis.\u201d Eligibility criteria were English-language, relevance to PD and specification of \u201csystematic review\u201d or \u201cmeta-analysis\u201d in the title or abstract. Oxford Center for Evidence-Based Medicine levels of evidence were used to classify original studies reviewed within each publication. Risk of bias was assessed using the ROBIS tool. Data were tabulated and reported as means with standard deviation, median with interquartile range and t-testing as appropriate. Strength of association between variables was calculated using Pearson correlation coefficient. Statistical analyses were performed on RStudio (version 1.4.1106).<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes<\/jats:title><jats:p>Outcomes included review type, level of evidence, authorship, journal, publication date, \u201cA MeaSurement Tool to Assess systematic Reviews\u201d (AMSTAR-2) score and \u201cPreferred Reporting Items for Systematic Reviews and Meta-Analyses\u201d (PRISMA) score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1974 to 2021, 340 articles were identified. After review, 17 full length articles were included. Thirteen were SR, 2 MA and 2 was combined. Significant heterogeneity was seen in evidence level of included studies. There was median 54% adherence to AMSTAR-2 criteria and 74% adherence to PRISMA criteria. Overall AMSTAR-2 confidence rating was Critically Low in 11 of 17 studies. Correlation analysis revealed very high positive association between AMSTAR 2 and PRISMA adherence (+0.95). ROBIS revealed \u201cHigh\u201d concern regarding methods used to collect data and appraise 12\/17 studies (71%), and \u201cHigh\u201d concern regarding synthesis and findings in 8 of 17 studies (47%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Implications<\/jats:title><jats:p>Many SR include markedly heterogenous levels of evidence and fail to meet accepted methodological criteria for reporting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Strengths and Limitations<\/jats:title><jats:p>Main strengths include extensive literature review and analysis of standardized study reporting. One limitation is that aggregate scoring of AMSTAR-2 and PRISMA is not intended as primary method of quality assessment; however effect was minimized by reporting critical domains, overall quality assessments and specifics on globally poorly reported domains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>More high quality randomized controlled PD trials are necessary; SR and MA should focus on these studies alone.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jsxm.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T05:42:56Z","timestamp":1644903776000},"page":"629-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Critical Analysis of Reporting in Systematic Reviews and Meta-Analyses in the Peyronie\u2019s Disease Literature"],"prefix":"10.1093","volume":"19","author":[{"given":"Raevti","family":"Bole","sequence":"first","affiliation":[{"name":"Center for Men\u2019s Health, Glickman Urological and Kidney Institute, Cleveland Clinic , Cleveland, OH , USA"},{"name":"Department of Urology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison Chase","family":"Gottlich","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Ziegelmann","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Corrigan","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Mulhall","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan Kettering Cancer Center , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Bajic","sequence":"additional","affiliation":[{"name":"Center for Men\u2019s Health, Glickman Urological and Kidney Institute, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"2023041407183139000_","article-title":"Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence: Oxford Centre for Evidence-Based Medicine","author":"Howick","year":"2011"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"2023041407183139000_","article-title":"Center for Open Science (COS)","author":"Open Science Framework","year":"2021"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: A new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2023041407183139000_","article-title":"The Oxford 2011 levels of evidence","author":"Howick","year":"2011"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.esxm.2019.01.001","article-title":"Twenty years of plaque incision and grafting for Peyronie\u2019s disease: A review of literature","volume":"7","author":"Rice","year":"2019","journal-title":"Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jsxm.2018.12.011","article-title":"Comparative effectiveness of intralesional therapy for Peyronie\u2019s disease in controlled clinical studies: A systematic review and network meta-analysis","volume":"16","author":"Russo","year":"2019","journal-title":"J Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4111\/kju.2009.50.6.527","article-title":"Peyronie\u2019s disease: Current medical treatment and future perspectives","volume":"50","author":"Ryu","year":"2009","journal-title":"Korean J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.eururo.2018.07.005","article-title":"Clinical efficacy of injection and mechanical therapy for Peyronie\u2019s disease: A systematic review of the literature","volume":"74","author":"Russo","year":"2018","journal-title":"Eur Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ijir.2016.24","article-title":"A meta-analysis of extracorporeal shock wave therapy for Peyronie\u2019s disease","volume":"28","author":"Gao","year":"2016","journal-title":"Int J Impot Res"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","article-title":"The effect of adjunct mechanical traction on penile length in men undergoing primary treatment for Peyronie\u2019s disease: A systematic review and meta-analysis","volume":"122","author":"Haney","year":"2018","journal-title":"Urology"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","article-title":"Extracorporeal shock wave therapy for Peyronie\u2019s disease: Exploratory meta-analysis of clinical trials","volume":"171","author":"Hauck","year":"2004","journal-title":"J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1590\/1806-9282.65.10.1231","article-title":"Peyronie\u2019s disease: clinical treatment","volume":"65","author":"Aita","year":"2019","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.sxmr.2019.08.002","article-title":"Surgical treatment of Peyronie\u2019s disease: Systematic review of techniques involving or not tunica albuginea incision","volume":"8","author":"Barbosa","year":"2020","journal-title":"Sex Med Rev"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/13543784.2018.1495707","article-title":"Phase I and phase II clinical trials for the treatment of male sexual dysfunction-a systematic review of the literature","volume":"27","author":"Capogrosso","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"2023041407183139000_","first-page":"433","article-title":"Intralesional injection therapy and atypical Peyronie\u2019s disease: A systematic review","volume":"9","author":"Choi","year":"2020","journal-title":"Sex Med Rev"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/andr.12927","article-title":"Medical, non-invasive, and minimally invasive treatment for Peyronie\u2019s disease: A systematic review","volume":"9","author":"El-Sakka","year":"2021","journal-title":"Andrology"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41443-019-0189-9","article-title":"Strategies and current practices for penile lengthening in severe Peyronie\u2019s disease cases: A systematic review","volume":"32","author":"Falcone","year":"2020","journal-title":"Int J Impot Res"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-016-1834-2","article-title":"Extracorporeal shock wave therapy (ESWT) in urology: A systematic review of outcome in Peyronie\u2019s disease, erectile dysfunction and chronic pelvic pain","volume":"35","author":"Fojecki","year":"2017","journal-title":"World J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.esxm.2019.08.009","article-title":"Surgical management of Peyronie\u2019s disease with co-existent erectile dysfunction","volume":"7","author":"Krishnappa","year":"2019","journal-title":"Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.sxmr.2020.01.005","article-title":"Review of intralesional collagenase clostridium histolyticum injection therapy and related combination therapies in the treatment of Peyronie\u2019s disease (an Update)","volume":"9","author":"Natale","year":"2020","journal-title":"Sex Med Rev"},{"key":"2023041407183139000_","first-page":"160","article-title":"Long term outcomes of incision and grafting surgery for the treatment of peyronie\u2019s disease: A systematic review and meta-analysis","volume":"11","author":"Mandava","year":"2014","journal-title":"J Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bju.13754","article-title":"Raising the bar for systematic reviews with Assessment of Multiple Systematic Reviews (AMSTAR)","volume":"119","author":"Dahm","year":"2017","journal-title":"BJU Int"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.eururo.2010.01.034","article-title":"Low quality of evidence for robot-assisted laparoscopic prostatectomy: Results of a systematic review of the published literature","volume":"57","author":"Kang","year":"2010","journal-title":"Eur Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00345-018-2446-9","article-title":"The reporting quality of studies of diagnostic accuracy in the urologic literature","volume":"37","author":"Smith","year":"2019","journal-title":"World J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136540","article-title":"Reporting quality of systematic reviews and meta-analyses of otorhinolaryngologic articles based on the PRISMA statement","volume":"10","author":"Peters","year":"2015","journal-title":"PLoS One"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpurol.2019.12.002","article-title":"Assessing the methodological and reporting quality of clinical systematic reviews and meta-analyses in paediatric urology: Can practices on contemporary highest levels of evidence be built?","volume":"16","author":"O\u2019Kelly","year":"2020","journal-title":"J Pediatr Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/andr.12972","article-title":"The quality of systematic reviews and meta-analyses assessing the treatment and management of male infertility","volume":"9","author":"Bhambhvani","year":"2021","journal-title":"Andrology"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175213","article-title":"A systematic review of the quality of conduct and reporting of systematic reviews and meta-analyses in paediatric surgery","volume":"12","author":"Cullis","year":"2017","journal-title":"PLoS One"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00345-019-02914-4","article-title":"Infrequent use of clinical trials registries in published systematic reviews in urology","volume":"38","author":"Aro","year":"2020","journal-title":"World J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jsxm.2019.01.009","article-title":"The quality of systematic reviews and meta-analyses in erectile dysfunction treatment and management published in the sexual medicine literature","volume":"16","author":"Greenberg","year":"2019","journal-title":"J Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(07)61835-2","article-title":"CONSORT for reporting randomised trials in journal and conference abstracts","volume":"371","author":"Hopewell","year":"2008","journal-title":"Lancet"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ejo\/cjv094","article-title":"Reporting quality of randomized controlled trial abstracts presented at European Orthodontic Society congresses","volume":"38","author":"Hua","year":"2016","journal-title":"Eur J Orthod"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jsxm.2018.08.004","article-title":"Bibliometric analysis of erectile dysfunction publications in urology and sexual medicine journals","volume":"15","author":"Rezaee","year":"2018","journal-title":"J Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.respol.2013.06.012","article-title":"Co-authorship networks and research impact: A social capital perspective","volume":"42","author":"Li","year":"2013","journal-title":"Res Policy"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.juro.2012.06.068","article-title":"Is intralesional verapamil effective therapy for Peyronie\u2019s disease?","volume":"188","author":"Levine","year":"2012","journal-title":"J Urol"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2008.01081.x","article-title":"Peyronie\u2019s disease intervention trials: Methodological challenges and issues","volume":"6","author":"Muller","year":"2009","journal-title":"J Sex Med"},{"key":"2023041407183139000_","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41443-020-0244-6","article-title":"Funding Peyronie\u2019s disease: Funding sources for primary research literature","volume":"33","author":"Christiansen","year":"2021","journal-title":"Int J Impot Res"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609522000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609522000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/4\/629\/49876814\/jsm_19_4_629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/4\/629\/49876814\/jsm_19_4_629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:55:53Z","timestamp":1700229353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/19\/4\/629\/6961260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2,14]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2022.01.008","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Critical Analysis of Reporting in Systematic Reviews and Meta-Analyses in the Peyronie's Disease Literature","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022, International Society of Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}